Publication | Closed Access

Tumor vasodilation by N-Heterocyclic carbene-based nitric oxide delivery triggered by high-intensity focused ultrasound and enhanced drug homing to tumor sites for anti-cancer therapy

NanomedicineEngineeringTheranosticsTumor VasodilationEnhanced DrugAnti-cancer TherapyNano-drug DeliveryTumor TargetingBiomedical EngineeringUltrasoundPharmacology